Science Explorer Back to mapMap
Discussion
Researcher · Centre d’Immunologie de Marseille-Luminy · France

Eric D. Vivier

Eric D. Vivier publishes mostly in Immunology, Oncology and Molecular Biology, on topics such as Immune Cell Function and Interaction, T-cell and B-cell Immunology and IL-33, ST2, and ILC Pathways.

ORCID 0000-0001-7022-8287 OpenAlex
World rank
#31,473
of 7,710,434 ranked researchers
Rank in France
#4,165
of 324,115
Works
695
Citations
64k
Citations per work
91.9
h-index
124
i10-index 361Top 0.2% in Immunology
Eric D. Vivier

What does Eric D. Vivier research?

Eric D. Vivier's work is mostly in Immunology and Microbiology (60%), Medicine (16%), Biochemistry, Genetics and Molecular Biology (6%).

Life Sciences: 457 works · 65.7% of their workImmunology and Microbiology: 417 works · 60.0% of their workImmunology: 417 works · 60.0% of their workBiochemistry, Genetics and Molecular Biology: 40 works · 5.7% of their workMolecular Biology: 40 works · 5.7% of their workEverything else: 129 works · 18.5% of their workHealth Sciences: 110 works · 15.8% of their workMedicine: 110 works · 15.8% of their workOncology: 56 works · 8.0% of their workSurgery: 25 works · 3.6% of their workEpidemiology: 15 works · 2.1% of their workHematology: 15 works · 2.1% of their workTHEIR WORKEric D. Vivier695works
Life Sciences66%Health Sciences16%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology41760.0%
    2. Biochemistry, Genetics and Molecular Biology405.7%
  2. Everything else12918.5%
    1. Medicine11015.8%
  1. 1Immunology60% of their works
  2. 2Oncology8% of their works
  3. 3Molecular Biology6% of their works
  4. 4Surgery4% of their works
  5. 5Hematology2% of their works
  6. 6Epidemiology2% of their works

Research topics

Which keywords describe Eric D. Vivier's research?

The keywords of their largest research topics: Natural Killer Cells, NK Cell Recognition, Foxp3, TGF-ß, Regulatory T Cells, Cancer Immunotherapy, IL-33 and Innate Lymphoid Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. NK Cell Recognition4311 topic
  2. Natural Killer Cells4311 topic
  3. Foxp32121 topic
  4. TGF-ß2121 topic
  5. Regulatory T Cells1432 topics
  6. Cancer Immunotherapy1262 topics
  7. IL-331111 topic
  8. Innate Lymphoid Cells1111 topic
  9. CAR T Cells861 topic
  10. Chimeric Antigen Receptor861 topic
  11. Diagnosis431 topic
  12. Eosinophilic Esophagitis431 topic
  13. Dendritic Cells401 topic
  14. Immunity401 topic
  15. Decidual NK Cells321 topic
  16. Fetal-Maternal Interface321 topic
  17. Pattern Recognition Receptors271 topic
  18. Toll-like Receptors271 topic

Where does Eric D. Vivier work?

Eric D. Vivier's main affiliation in the publication record is Centre d’Immunologie de Marseille-Luminy, France.

How many publications and citations does Eric D. Vivier have?

OpenAlex counts 695 works and 63,887 citations for Eric D. Vivier, an h-index of 124, ranking #31,473 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Eric D. Vivier. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.